Related Experiment Video
Updated: Mar 3, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Stigma perceptions in patients with eosinophilic gastrointestinal disorders
L Guadagnoli1, T H Taft1, L Keefer2
1Northwestern University Feinberg School of Medicine, Division of Gastroenterology and Hepatology, Chicago, Illinois, USA.
Perceived stigma negatively impacts the quality of life for individuals with eosinophilic gastrointestinal disorders (EGIDs). Addressing stigma is crucial for improving patient well-being and treatment effectiveness in EGID care.
Area of Science:
- Gastroenterology
- Psychology
- Public Health
Background:
- Eosinophilic gastrointestinal disorders (EGIDs) are chronic conditions requiring long-term management.
- The psychosocial impact of EGIDs, particularly perceived stigma, is not well understood.
- Understanding stigma's role is vital for comprehensive patient care.
Purpose of the Study:
- To assess perceived stigma in patients with self-reported EGIDs.
- To examine the relationship between perceived stigma and health-related quality of life (HRQoL).
- To investigate the association of stigma with other psychosocial outcomes.
Main Methods:
- A cross-sectional study involving 149 patients diagnosed with EGIDs for at least 6 months.
- Participants completed validated questionnaires assessing perceived stigma, psychological functioning, and HRQoL.
- Statistical analyses explored correlations between stigma and patient-reported outcomes.
Main Results:
- Perceived stigma showed a moderate association with decreased HRQoL and treatment efficacy.
- Higher levels of perceived stigma correlated with increased anxiety, depression, and healthcare utilization.
- Stigma significantly influences multiple aspects of health and well-being in EGID patients.
Conclusions:
- Perceived stigma is a significant issue for individuals with EGIDs, affecting their quality of life.
- Healthcare professionals must recognize and address stigma to improve patient outcomes.
- Interventions targeting stigma reduction may enhance psychological well-being and reduce healthcare use in EGID patients.
Related Concept Videos
Other Disorders of Digestive System
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

